Dogecoin Cash, Inc. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that Dogecoin Cash, Inc. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $738.9K | Mar 27, 2026 |
| FY2025 | Dec 31, 2024 | $802.7K | Mar 27, 2026 |
| FY2024 | Dec 31, 2023 | $1.17M | Apr 16, 2025 |
| FY2023 | Dec 31, 2022 | $1.56M | Jan 24, 2025 |
| FY2022 | Dec 31, 2021 | $1.84M | Apr 20, 2023 |
| FY2022 | Dec 31, 2020 | $1.94M | Apr 14, 2022 |
| FY2020 | Dec 31, 2019 | $1.16M | Apr 16, 2021 |
| FY2019 | Dec 31, 2018 | $505.7K | May 14, 2020 |
| FY2018 | Jun 30, 2018 | $206.5K | Aug 20, 2018 |
| FY2018 | Dec 31, 2017 | $318.0K | Apr 4, 2019 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $473.2K | Mar 27, 2026 |
| FY2025 | Dec 31, 2024 | $492.1K | Mar 27, 2026 |
| FY2024 | Dec 31, 2023 | $773.1K | Apr 16, 2025 |
| FY2023 | Dec 31, 2022 | $960.9K | Jan 24, 2025 |
| FY2022 | Dec 31, 2021 | $1.14M | Apr 20, 2023 |
| FY2022 | Dec 31, 2020 | $1.20M | Apr 14, 2022 |
| FY2020 | Dec 31, 2019 | $696.8K | Apr 16, 2021 |
| FY2019 | Dec 31, 2018 | $295.8K | May 14, 2020 |
| FY2018 | Jun 30, 2018 | $138.9K | Aug 20, 2018 |
| FY2018 | Dec 31, 2017 | $163.5K | Apr 4, 2019 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($2.46M) | Mar 27, 2026 |
| FY2025 | Sep 30, 2025 | ($178.4K) | Mar 27, 2026 |
| FY2025 | Jun 30, 2025 | ($7.30M) | Mar 27, 2026 |
| FY2025 | Mar 31, 2025 | ($107.4K) | Mar 27, 2026 |
| FY2025 | Dec 31, 2024 | ($925.8K) | Mar 27, 2026 |
| FY2025 | Sep 30, 2024 | ($241.1K) | Mar 27, 2026 |
| FY2025 | Jun 30, 2024 | ($390.8K) | Mar 27, 2026 |
| FY2025 | Mar 31, 2024 | ($222.6K) | Mar 27, 2026 |
| FY2024 | Dec 31, 2023 | ($1.32M) | Apr 16, 2025 |
| FY2023 | Dec 31, 2022 | ($1.26M) | Jan 24, 2025 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($546.7K) | Mar 27, 2026 |
| FY2025 | Dec 31, 2024 | ($693.2K) | Mar 27, 2026 |
| FY2024 | Dec 31, 2023 | ($855.9K) | Apr 16, 2025 |
| FY2023 | Dec 31, 2022 | ($1.40M) | Jan 24, 2025 |
| FY2022 | Dec 31, 2021 | ($1.75M) | Apr 20, 2023 |
| FY2022 | Dec 31, 2020 | ($1.79M) | Apr 14, 2022 |
| FY2020 | Dec 31, 2019 | ($3.81M) | Apr 16, 2021 |
| FY2019 | Dec 31, 2018 | ($5.04M) | May 14, 2020 |
| FY2018 | Jun 30, 2018 | ($1.09M) | Aug 20, 2018 |
| FY2018 | Dec 31, 2017 | ($7.85M) | Apr 4, 2019 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2015 | Dec 31, 2014 | $3.7K | May 6, 2016 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($39.6K) | Mar 27, 2026 |
| FY2025 | Dec 31, 2024 | ($107.7K) | Mar 27, 2026 |
| FY2024 | Dec 31, 2023 | ($63.1K) | Apr 16, 2025 |
| FY2023 | Dec 31, 2022 | ($235.6K) | Jan 24, 2025 |
| FY2022 | Dec 31, 2021 | ($246.0K) | Apr 20, 2023 |
| FY2022 | Dec 31, 2020 | ($191.8K) | Apr 14, 2022 |
| FY2020 | Dec 31, 2019 | $94.6K | Apr 16, 2021 |
| FY2019 | Dec 31, 2018 | ($689.9K) | May 14, 2020 |
| FY2018 | Jun 30, 2018 | ($421.4K) | Aug 20, 2018 |
| FY2018 | Dec 31, 2017 | ($964.7K) | Apr 4, 2019 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2023 | Dec 31, 2023 | $0 | Jan 24, 2025 |
| FY2023 | Dec 31, 2022 | $1.6K | Jan 24, 2025 |
| FY2022 | Dec 31, 2021 | $0 | Apr 20, 2023 |
| FY2022 | Dec 31, 2020 | $58.5K | Apr 14, 2022 |
| FY2020 | Dec 31, 2019 | $2.4K | Apr 16, 2021 |
| FY2019 | Dec 31, 2018 | $630 | May 14, 2020 |
| FY2018 | Jun 30, 2018 | $630 | Aug 20, 2018 |
| FY2018 | Dec 31, 2017 | $9.6K | Apr 4, 2019 |
| FY2018 | Jun 30, 2017 | $0 | Aug 20, 2018 |
| FY2017 | Dec 31, 2016 | $0 | Apr 9, 2018 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.23M | Mar 27, 2026 |
| FY2025 | Dec 31, 2024 | $1.71M | Mar 27, 2026 |
| FY2024 | Dec 31, 2023 | $2.02M | Apr 16, 2025 |
| FY2023 | Dec 31, 2022 | $2.57M | Jan 24, 2025 |
| FY2022 | Dec 31, 2021 | $2.56M | Apr 20, 2023 |
| FY2022 | Dec 31, 2020 | $3.21M | Apr 14, 2022 |
| FY2020 | Dec 31, 2019 | $2.98M | Apr 16, 2021 |
| FY2019 | Dec 31, 2018 | $4.87M | May 14, 2020 |
| FY2018 | Jun 30, 2018 | $6.38M | Aug 20, 2018 |
| FY2018 | Dec 31, 2017 | $7.71M | Apr 4, 2019 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.26M | Mar 27, 2026 |
| FY2025 | Dec 31, 2024 | $1.84M | Mar 27, 2026 |
| FY2024 | Dec 31, 2023 | $1.26M | Apr 16, 2025 |
| FY2023 | Dec 31, 2022 | $986.3K | Jan 24, 2025 |
| FY2022 | Dec 31, 2021 | $1.52M | Apr 20, 2023 |
| FY2022 | Dec 31, 2020 | $1.58M | Apr 14, 2022 |
| FY2020 | Dec 31, 2019 | $1.82M | Apr 16, 2021 |
| FY2019 | Dec 31, 2018 | $1.57M | May 14, 2020 |
| FY2018 | Jun 30, 2018 | $2.05M | Aug 20, 2018 |
| FY2018 | Dec 31, 2017 | $1.50M | Aug 20, 2018 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($1.87M) | Mar 27, 2026 |
| FY2025 | Dec 31, 2024 | ($1.44M) | Mar 27, 2026 |
| FY2024 | Dec 31, 2023 | ($602.5K) | Apr 16, 2025 |
| FY2023 | Dec 31, 2022 | $293.9K | Jan 24, 2025 |
| FY2022 | Dec 31, 2021 | ($293.2K) | Apr 20, 2023 |
| FY2022 | Dec 31, 2020 | $660.2K | Apr 14, 2022 |
| FY2020 | Dec 31, 2019 | $2.1K | Apr 16, 2021 |
| FY2019 | Dec 31, 2018 | $2.07M | May 14, 2020 |
| FY2018 | Jun 30, 2018 | $2.48M | Aug 20, 2018 |
| FY2018 | Dec 31, 2017 | $4.20M | Apr 4, 2019 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.28M | Mar 27, 2026 |
| FY2025 | Dec 31, 2024 | $1.28M | Mar 27, 2026 |
| FY2024 | Dec 31, 2023 | $1.78M | Apr 16, 2025 |
| FY2023 | Dec 31, 2022 | $1.84M | Jan 24, 2025 |
| FY2022 | Dec 31, 2021 | $1.84M | Apr 20, 2023 |
| FY2022 | Dec 31, 2020 | $1.84M | Apr 14, 2022 |
| FY2020 | Dec 31, 2019 | $1.84M | Apr 16, 2021 |
| FY2019 | Dec 31, 2018 | $2.17M | May 14, 2020 |
| FY2018 | Jun 30, 2018 | $3.35M | Aug 20, 2018 |
| FY2019 | Dec 31, 2017 | $3.35M | May 14, 2020 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($84.39M) | Mar 27, 2026 |
| FY2025 | Dec 31, 2024 | ($83.82M) | Mar 27, 2026 |
| FY2024 | Dec 31, 2023 | ($82.08M) | Apr 16, 2025 |
| FY2023 | Dec 31, 2022 | ($80.69M) | Jan 24, 2025 |
| FY2022 | Dec 31, 2021 | ($79.48M) | Apr 20, 2023 |
| FY2022 | Dec 31, 2020 | ($77.03M) | Apr 14, 2022 |
| FY2020 | Dec 31, 2019 | ($74.86M) | Apr 16, 2021 |
| FY2019 | Dec 31, 2018 | ($70.92M) | May 14, 2020 |
| FY2018 | Jun 30, 2018 | ($68.83M) | Aug 20, 2018 |
| FY2018 | Dec 31, 2017 | ($66.79M) | Apr 4, 2019 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $29.6K | Mar 27, 2026 |
| FY2025 | Dec 31, 2024 | $34.9K | Mar 27, 2026 |
| FY2020 | Dec 31, 2020 | $322.1K | Apr 16, 2021 |
| FY2020 | Dec 31, 2019 | $336.1K | Apr 16, 2021 |
| FY2020 | Dec 31, 2018 | $151.9K | Apr 16, 2021 |
| FY2019 | Dec 31, 2017 | $175.9K | May 14, 2020 |
| FY2018 | Dec 31, 2016 | $257.7K | Apr 4, 2019 |
| FY2017 | Dec 31, 2015 | $10.4K | Apr 9, 2018 |
| FY2016 | Dec 31, 2014 | $26.0K | May 5, 2017 |
| FY2015 | Dec 31, 2013 | $14.9K | May 6, 2016 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2023 | Dec 31, 2023 | 0 | Jan 24, 2025 |
| FY2023 | Dec 31, 2022 | 0 | Jan 24, 2025 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 160.11M | Mar 27, 2026 |
| FY2025 | Dec 31, 2024 | 143.90M | Mar 27, 2026 |
| FY2024 | Dec 31, 2023 | 88.81M | Apr 16, 2025 |
| FY2023 | Dec 31, 2022 | 45.57M | Jan 24, 2025 |
| FY2022 | Dec 31, 2021 | 30.75M | Apr 20, 2023 |
| FY2022 | Dec 31, 2020 | 27.45M | Apr 14, 2022 |
| FY2020 | Dec 31, 2019 | 22.22M | Apr 16, 2021 |
| FY2019 | Dec 31, 2018 | 21.32M | May 14, 2020 |
| FY2018 | Jun 30, 2018 | 20.87M | Aug 20, 2018 |
| FY2018 | Dec 31, 2017 | 20.80M | Apr 4, 2019 |